Membrane cofactor protein (MCP) is a complement regulatory protein that is expressed on human cells and cell lines as two relatively broad species with M, of 58,000-68,000 and 48,000-56,000. The structure of a previously reported cDNA clone indicated that MCP was a type 1 membrane glycoprotein and a member of the regulators of complement activation gene/protein cluster. However, it did not provide an explanation for the unusual phenotypic pattern ofMCP. Therefore, in parallel with an analysis of the gene, additional cDNAs were cloned and characterized . Six different MCP cDNA classes were identified. All encode the same 5' untranslated signal peptide, four SCRs, transmembrane domain, and basic amino acid anchor. However, they differ in the length and composition of an extracellular serine/threonine/proline (STP)-rich area, a site of heavy O-glycosylation, and cytoplasmic tail. Analysis of the MCP gene demonstrated that the variation in cDNA structure was a result of alternative splicing. Peripheral blood cells and cell lines predominantly expressed four of the six isoforms. These varied by the presence or absence of an STP-rich segment of 15 amino acids (STPB) and by the use of one of two cytoplasmic domains . Analysis by polymerase chain reaction, Northern blots, and transfection indicated that the predominance of MCP cDNA isoforms with STPB correlated with the high molecular weight protein phenotype, while the predominance of isoforms without STPB correlated with the lower molecular weight phenotype . The expression in a single cell of four distinct protein species with variable STP-rich regions and cytoplasmic tails represents an interesting example of the use of alternative splicing to provide variability in a mammalian protein .
M embrane cofactor protein (MCP;t CD46) is a widely distributed regulatory protein of the complement system that binds to the complement activation products C3b and C4b and serves as a cofactor for their proteolytic inactivation by factor I (1-3). Except for erythrocytes, MCP has been found on nearly every cell and tissue examined: cells of epithelial, endothelial, and fibroblast lineages (4, 5) , PBL (6) (7) (8) , platelets (5, 7, 9) , sperm (10), trophoblast tissues (11) (12) (13) , and in serum, saliva, and seminal fluid (5) . Because of this tissue distribution and functional profile, it has been postulated that MCP helps prevent complement activation on host cells (reviewed in references 14 and 15) . Recently, this hy-in references 1 and 23) , at which the structural gene for MCP also maps (24) (25) (26) . Immediately 3' of the SCRs is a serine/ threonine/proline (STP)-rich region, a likely area for extensive O-glycosylation. This is followed by a short segment of unknown significance, a transmembrane domain, basic amino acid anchor, and a cytoplasmic tail .
We now report six additional cDNA clones, each encoding a distinct protein class of MCP. Using PCR of mRNA, Northern blots, and transfections of cDNAs, we demonstrate that four of these isoforms are predominantly expressed by peripheral blood cells and cell lines. Through the cloning and characterization of the MCP gene, we show that alternative splicing produces these distinct classes of MCP and that the presence or absence of an STP-rich exon determines the protein phenotype.
Materials and Methods
Construction and Screening ofcDNA and Genomic Libraries. A cDNA library was prepared from 10 p.g of HeLa poly(A)' RNA (Clontech, Palo Alto, CA). cDNA inserts were size selected to be >3 kb by agarose gel electrophoresis, ligated into A Zap' 11, packaged in Gigapack' Gold, and plated on XLl-Blue Escherichia coli (all from Stratagene, La Jolla, CA). This library was probed with MCP-1 cDNA (22) , which was labeled by random hexanucleotide priming (27) .
Two human genomic bacteriophage libraries, obtained from the American Type Culture Collection (ATCC; Rockville, MD) and Stratagene, were constructed by partial EcoRl or Sau3A1 digestion of human genomic DNA, followed by insertion into the vectors Charon 4A and XDASH, respectively. They were screened by standard techniques (27) with MCP cDNA or MCP genomic DNA labeled by random hexanucleotide priming. A chromosome 1-specific library (from ATCC) was also screened with a 3' UT specific oligonucleotide labeled at its 5' end by T4 kinase. This library was constructed by complete EcoRl digestion followed by insertion into the vector Charon 21A.
DNA Isolation and Subdoning. Positive clones from the Zap' II HeLa library were plaque purified followed by in vivo excision of the phagemid per manufacturer's protocol (Stratagene) . Positive clones from the genomic library were plaque purified, and DNA was isolated using a small-scale bacteriophage preparation (28) . Bacteriophage insert DNA was subcloned into the EcoRl site of pUC 19 by standard techniques (27) .
RNA Isolation . Total RNA was isolated from cell lines or peripheral blood cells by either the guanidium isothiocyanate/CsCl (29) or acid phenol (30) methods. PBMC were isolated using standard Ficoll-Hypaque separation methods (6, 31) . Isolated RNA was quantitated by either optical density or ethidium bromide staining of agarose gels (27) . Previously studied human cell lines used in this investigation were U-937 (monocyte/macrophage), K-562 (erythroleukemia), HSB-2 (T lymphocyte), Hela (carcinoma of the cervix), and HEp-2 (carcinoma of the larynx) (4, 6) .
cDNA Synthesis and PCR ofFulllength cDNA. 20 pg of total RNA, obtained from K-562 and HEp-2 cell lines, as described above, was used for each first-strand synthesis reaction . RNA was incubated at 65°C for 3 min and then quick-chilled at 4°C. First-strand cDNA synthesis was then performed using the Copy Kit (Invitrogen, San Diego, CA); however, a 3' UT MCP-specific antisense primer was used in place of oligo(dT) or random primers. This primer was AAGCCACATTGCAATATTAGCTAAGCCACAGT First strand cDNA was then ethanol precipitated and the product was used
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Multiple Isoforms of Membrane Cofactor Protein for each subsequent PCR. Except for primers, reagents used for the PCR were from the GeneAmp' kit (Perkin Elmer Cetus, Norwalk, CT). The MCP-specific primers were as follows: the 5' primer possessed an EcoRl site added to the 5' UT MCP sequence of ATTGTTGCGTCCCATATCTGGACCCAGAAGGG; the antisense MCP primer was the same as used for first-strand synthesis, except an EcoR1 restriction site was added. Cycling conditions were an initial denaturation of 94°C for 5 min followed by 39 cycles consisting of a denaturation temperature of 94°C for 1 min, an annealing temperature of 55"C for 1 min, and an extension temperature of 72°C for 2 min. At the completion of the cycling reactions, a final extension was performed for 10 min at 72°C . The PCR products were ethanol precipitated, digested with EcoRl, and gel isolated . The product was then subcloned into the EcoRl site of pUC 19 . Distinct clones were sequenced in their entirety.
DNA Sequence Determination and Mapping. Double-stranded DNA sequencing was performed using the Sequenase Kit (United States Biochemical Corp., Cleveland, OH). Sequencing primers included forward and reverse M13 primers and synthesized oligonucleotides corresponding to known regions of MCP cDNA and MCP intron-specific sequences. Bacteriophage inserts of genomic clones were aligned by restriction mapping, hybridization to MCP exonand intron-specific probes, and sequencing.
Northern Blots. Total RNA was isolated (as above) . RNA samples, along with RNA markers (0 .24-9.5 kb; Bethesda Research Laboratories, Gaithersburg, MD) were run on a 1% agarose gel by standard methods (27) , except that the concentration of formaldehyde in the gel was decreased to 0.22 M. Gels were blotted onto Nitroplus 2000 membrane (Micron Separations, Inc., Westborough, MA). Blots were hybridized and washed at high stringency (27) .
cDNA Synthesis and PCR for "Short Form" ofcDNA . 2 Ag of U-937, 10 ug of K-562, 12 ttg of HSB-2, 9 pg of HeLa, 0.2 p.g of HEp-2 total RNA, and 5-20 Itg of six individuals' peripheral blood cells total RNA were used for each first-strand synthesisreaction in a total volume of 20 pi (Copy Kit; Invitrogen) . Reagent concentrations were as per manufacturer's protocol, except that both oligo(dT) and random primers were used . Two first-strand controls were used . One was the same amount of cell line RNA and all reaction reagents but without reverse transcriptase . The other was 20 hg of yeast tRNA with all first-strand reaction reagents including reverse transcriptase. First-strand reaction mixtures were incubated for 2 h at 42°C and then at 72'C for 10 min before being ethanol precipitated and resuspended in 30 pl of water.
PCR amplification was performed as described earlier using GeneAmp' Kit, except that cycling numbers were varied to provide linearity of the reaction . The sequence of the 5' MCP-specific primer was TGTCGACTGGAATTCCTGGTCAAATGTCGATT TCCAGTAGTCGAAAAT, and of the 3' primer was GATATTCA-CCTGCAGGAAGCCACATTGCAATATTAGCTAAGCCACAGT The PCR product was analyzed on a 3% agarose gel. PCR experiments using plasmids containing known MCP cDNAs were performed as above. The PCR products from cell lines and plasmids were analyzed by digestion with either Sall or Stul .
Transfection ofMCP Isoforms . The cDNA isoforms were subcloned into the EcoRl site of the expression vector SFFVneo (32) . Plasmid DNA was subsequently prepared using the pZ523 kit from 5 Prime 3 Prime, Inc. (West Chester, PA). Chinese Hamster Ovary cells (CHO-K1; ATCC), were then transfected with the prepared DNA using Lipofectin' Reagent (Bethesda Research Laboratories) following the manufacturer's suggestion for preparation of stable transfectants . CHO cells were grown in Ham's F-12 with 10% FCS, penicillin (100 U/ml), and streptomycin (100 ug/ml) . 2 d after transfection, cells were grown in the same medium supplemented with Geneticin® (0.5 mg/ml activity concentration) (Gibco Laboratories, Grand Island, NY) . Transfected cells were sorted on an EPIC 753 (Coulter Corp., Hialeah, FL) one to four times depending on expression levels .
Labeling and Immunoprecipitation ofCells. Unless otherwise indicated, reagents were obtained from Sigma Chemical Co. (St. Louis, MO). Cell lines and stably transfected cells, the latter grown to 70-80% confluency, were washed and "starved" for 1 h at 37°C in cysteine-free medium containing 10% dialyzed FCS. After this, "S-cysteine was added (100 uCi/ml) (1,000 Ci/mmol ; New England Nuclear, Boston, MA), and the incubation continued for 4 h. PBMC were surface labeled with~..I (6) .
To immunoprecipitate MCP, cells were solubilized in lysis buffer (1% NP-40 in 10 mM TRIS, pH 7.4, 150 mM NaCl, 0.05% SDS, 2 mM PMSF, and 2.5 mM EDTA). After incubating at 4°C for 20 min, cell debris was pelleted at 10,000g for 10 min . Cell lysate supernatants were "pre-cleared" for 30 min at 4°C by adding 5 Al normal rabbit serum, 10 ill (10 Ag) UPC-10 (a mouse monoclonal IgG2a of unknown specificity), and 50 p,l packed protein A-agarose (Boehringer Mannheim Biochemicals, Indianapolis, IN) . The "cleared" supernatant was then incubated for 1 h at 4°C with 5 pl of ascites fluid containing E4.3, an IgG2a mAb to MCP (33) (34) (35) . Subsequently, 15 Ell ofprotein A-agarose was incubated for 20 min . After washing the pelleted sample with cell lysis buffer containing 0.5 M NaCl, gel buffer was added and the sample heated to 100°C for 3 min . Gel buffer contained 10% (vol/vol) glycerol, 0.2% SDS, 62 mM TRIS-HCI (pH 6.8) . The supernatant was fractionated on a 10% SDS polyacrylamide gel using the Laemmli system (36). Gels were fixed, stained, treated with Amplify (Amersham Corp., Arlington Heights, IL), dried, and exposed to Kodak XAR film.
Results
Multiple MCP cDNAs. The initial MCP cDNA clone (MCP-9) did not provide an explanation for the two bands on SDS-PAGE and was nearly 2 kb smaller than the major transcript (22) . Therefore, additional MCP cDNA clones were sought by screening a cDNA library and by PCR. Since HeLa cells express a relatively large quantity of both MCP species (4), a size-selected (>3 .0 kb) cDNA library was prepared and two informative clones were characterized. Clone HL-1 possessed sequence identical to MCP-9 (22) submitted to the GenBank~`/EMBL Data Bank). A Northern blot, using total RNA from K-562, U-937, HeLa, and HEp-2 cell lines, was hybridized at high stringency with a 0.6-kb EcoRl fragment unique to this additional 3' UT sequence. The blot indicated that this sequence was transcribed and was part of the major transcript of all four cell lines (data not shown) . Additionally, HIA possessed the more common polyadenylation signal AATAAA, as opposed to the atypical signal of MCP-9 (AATATA or AATGAA) (22) . Another clone from the HeLa Library (HL27) was identical to HL1, except for a 93-bp sequence located immediately after the transmembrane domain. Because ofan inframe stop codon, this segment coded for an alternate cytoplasmic tail of 16 amino acids followed by 45 nt of 3' UT sequence (Fig. 2 A) . The remaining 3' UT sequence in HL-27 was identical to the cDNA sequence ofHL1 . Thus, the sequence for the cytoplasmic tail identified in the original MCP clone (MCP-9) (22) became part of the 3' UT area in clone HL-27 . Due to the ordering of these segments, this alternate tail of clone HL27 was designated CYTI, and the initially characterized MCP cytoplasmic tail was designated CYT 2. A Northern blot, hybridized at high stringency with an antisense oligonucleotide to this 93-bp insert, demonstrated that all four of the cell lines examined possessed transcripts bearing this insert but that the quantity was variable (Fig. 2 B) .
PCR was also used to generate cDNAs. MCP-specific primers from the 5' UT and 3' UT regions were used to produce clones that span the coding region of MCP. From both K-562 and HEp-2 total RNA, these primers produced PCR products of -1.4 kb. Subclones, sequenced in their entirety, revealed four additional forms of MCP cDNA.
Clones K5-9 and K5-22, derived from cell line K-562, possessed an additional segment immediately after SCR-4 and before the previously defined STP region of MCP. This segment was termed STP^ (Figs. 3 and 4) because, if translated, .9 of 15 amino acids were S, T, or P. The cDNA bearing this 45-nt insert appeared with CYTI in clone K5-9 and with CYT2 in clone K5-22 (Fig. 4) . A Northern blot, hybridized with an antisense probe in STPA, gave a weak signal (data not shown), suggesting that transcripts bearing this insert represented rare species in the four cell lines examined (also, see below) .
PCR of HEp-2 total RNA yielded two other clones, H2-14 and H2-15, in which a portion of the STP region, termed STPB, was deleted. H2-14 and H2-15 were identical except that H2-14 contained CYTI and H2-15 contained CYT 2. Fig. 4 summarizes the clones characterized. Of note, the addition of CYTI and STPA, or deletion of STPB, did not disrupt the reading frame.
PCR Analysis ofthe Variable Regions within MCP mRNAs.
We next asked which of the six transcripts were commonly expressed . To answer this, two primers spanning the area of variability, from SCR-4 to the 3' UT region, were used in the PCR.
The PCR products derived from the total RNA of the cell lines were found to consist of variable quantities of four bands (Fig. 5) . To identify these products, the same primers were used to amplify this area from cloned full-length MCP Figure 3 . nt and derived amino acid sequence of STPA . This 45-nt insert codes for 15 amino acids, of which nine are S, T, or P. The insert is positioned immediately after SCR-4 and before the previously described STP region (see Fig. 1 ) .
cDNAs bearing known isoforms (Fig. 6 ) . The resultant product was compared with those obtained from the HeLa cell line. The known PCR products of Fig . 6 , lanes 1, 2, 5, and 6 align with the four bands from HeLa cells, and also have the expected size for their respective mRNAs .
To further verify the identity of the four PCR products, a restriction enzyme analysis was undertaken . A Salt site is located in the sequence of STPB, and a Stul site is in STPB 9 6 Multiple Isoforms of Membrane Cofactor Protein (22) . Only the PCR products from clones bearing STPB were cut by Sall into the anticipated fragments (Fig. 7 , lanes 3 and 5) . All four PCR products were cut by Stul into fragments of the expected size (lanes 6-9), indicating they are derived from cDNA inserts with STPB . If the PCR products of each cell line are the same as the products from the known cDNA clones, they should be digested in a similar fashion. Consequently, PCR products derived from HeLa were digested with Sall and compared with the undigested products (Fig. 8) . Bands 1 and 3 were not cut, while bands 2 and 4 were digested into the fragments of the expected size. In addition, all four bands were digested with Stul, and the correct fragments were produced (Figs . 7 and 8 
8, lane 7)
. This same pattern of enzyme digestion was found for U-937, HEp-2, and HSB-2 cell lines (data not shown) . Therefore, the PCR products amplified in the cell lines are the same as known MCP RNA isoforms (Fig. 6) . Bands 1 and 3 represent mRNA species that contain STPC with either CYTZ (band 3) or CYTZ (band 1), while bands 2 and 4 represent those that contain STPB and STPB with either CYTZ (band 4) or CYTZ (band 2) .
Correlation ofProtein Phenotype to mRNA Isoforms. PCR, Northern blot, and transfection analyses were undertaken to determine ifthere was a correlation between the mRNA species and protein phenotype.
PCR Analysis . Total RNA, derived from cell lines and from peripheral blood cells of individuals possessing the three protein phenotypes, was examined by PCR. The identity of the PCR products was verified by restriction enzyme analysis (data not shown) . The relative amounts of bands 2 (with STPB and CYTZ) and 4 (with STPB and CYTZ) were increased in individuals expressing predominantly the larger protein phenotype of MCP (Fig. 9) . In contrast, the relative amounts of bands 1 (without STPB and with CYTZ) and 3 (without STPB and with CYTZ) were increased in individ- 97 Post et al. uals expressing predominantly the lower protein phenotype, and comparable quantities of bands 1 and 3 vs. 2 and 4 were present in individuals expressing equal quantities of the lower and upper protein forms. Also, this same correlation was ob- served in the cell lines (Fig. 5) ; thus, mRNA of cell lines expressing mostly the higher molecular weight protein phenotype (U-937, K-562, and HSB-2) produced predominantly PCR bands 2 and 4; the lower molecular weight protein phenotype (Hep-2), bands 1 and 3; and the equal protein phenotype (HeLa), comparable quantities of bands 1 and 3 vs. 2 and 4 . Northem Analysis. A Northern blot containing total RNA from several cell lines was probed with two antisense oligonucleotide probes ft 10) . One probe was antisense to SCR-4, while the other was antisense to all of STPB. A plasmid containing both the SCR-4 and STPB was used as a positive control . Two cell lines (U-937 and K-562) expressing predominantly the larger protein phenotype demonstrated comparable hybridization signals to both probes (Fig. 10) . However, a cell line (HeLa) expressing about equal quantities and the other one (HEp-2) expressing primarily the lower protein form demonstrate a diminished signal to the probe to STPB, as compared with the signal from SCR-4 . Therefore, this Northern blot analysis supported the results obtained by PCR and indicated that the presence or absence of STPB determines the protein phenotype.
Transfection. CHO cells were transfected with the cDNAs and the expressed proteins were precipitated and analyzed by SDS-PAGE followed by autoradiography (Fig. 11) . Cells trans- fected with cDNAs containing STPB migrated with an M of 45,000-55,000 (Fig. 11, lanes 3 and 4) . In contrast, MCP expressed in CHO cells with STPB migrated with an Mr of 55,000-65,000 (Fig. 11, lanes 7 and 8) . The Mr of the expressed proteins were similar to those of MCP of cell lines (lanes 5 and 6) and of PBMC (lanes 2 and 10) . The type of cytoplasmic tail had no detectable effect on the Mr . Thus, the presence of STPB defines the larger protein phenotype and its absence produces the lower protein phenotype. These results are entirely consistent with the PCR and Northern analyses. The MCP cDNA containing STP"c was also expressed and had an Mr of 65,000-75,000 (Fig. 11, lane 9) . Such species have not been detected on human peripheral blood cells or cell lines (4, 6, 7, 18, 19) (Fig. 11, lanes 2, 5, 6, and 10) . Therefore, these results are consistent with those derived from Northern blots (Fig . 3) and PCR (Figs . 5 and 6) , and indicate that STPABC bearing mRNAs are rare in these cell populations.
Organization ofthe MCP Gene To determine how the isoforms arise, three genomic bacteriophage libraries were screened and genomic fragments obtained that contained 14 exons and 13 introns of the MCP gene (Fig. 12) . These exons, spread over a length of -43 kb, contained one area that did not overlap. All exons and surrounding intronic areas were sequenced . The exonic sequences matched those of MCP cDNAs and PCR clones. All exon/intron boundaries conformed to the GT/AG consensus sequence rule (37) , and SCR-4 are encoded by a single exon, while SCR-2 is encoded by two equally sized exons. Interestingly, this "split" exon occurs after the second nt of glycine 34. This pattern is identical to the split exons of other complement regulatory proteins (1). Exons 7, 8, and 9 encode the three STPrich areas. Since the 5' donor splice site ofexons 7 and 8 occurs after the first nt of the triplet codon, the addition or deletion of these exons does not disrupt the reading frame. Interestingly, exons 7 and 8 have an overall homology of -70%. Moreover, there is extensive homology in the 3' acceptor and 5' donor introns ofboth of these exons (Fig. 13) , indicating that these exons arose by intragenic duplication .
Exon 10 encodes for a 13 amino acid stretch of unknown significance. Exons 11 and 12 encode for the hydrophobic transmembrane domain and the basic amino acid anchor. Exon 13 encodes for the 93-nt segment CYT 1. If axon 13 is present in a transcript, this nt sequence codes for a cytoplasmic tail of 16 amino acids. Since this exon also codes for an inframe stop codon, the presence of exon 13 converts exon 14 into the 3' UT region of MCP. If exon 13 is not present, then exon 14 encodes the cytoplasmic tail of 23 amino acids, named CYT 2, and the 3' UT region of MCP. Discussion An unusual aspect of MCP is the variable expression of two relatively broad protein species (2, 3, 6) . The goal of the present investigation was to determine the molecular basis of this phenotypic observation . The approach taken was to identify and characterize additional cDNA clones. As this was progressing, the organization of the MCP gene was also being determined. Six unique mRNA species were characterized . Each mRNA encoded for an identical 5' UT region, signal peptide, four SCRs, transmembrane domain, and basic amino acid anchor. Due to variable splicing, the cDNAs differed in the length of the STP-rich area and in the type of cytoplasmic tail. Alternative splicing produces three different STP-rich regions and two distinct cytoplasmic tails. The alternative splicing event that gives rise to the two tails occurs with each of the splicing events involving the STP exons ; that is, each variation in the STP region was found with each tail.
To relate these molecular observations to those previously made at the protein level, three types ofmRNA analyses were performed . PCR analysis, using primers encompassing the area ofvariability within the mRNA, demonstrated that variable quantities of four primary MCP mRNA species were expressed in cell lines and in peripheral blood cells. Two of these mRNA species possessed and two lacked STPB. Northern blots indicated that the relative predominance of isoforms with STPB correlated with the higher molecular weight protein phenotype, while the predominance of isoforms without STPB correlated with the lower molecular weight protein phenotype. This finding was supported by transfection analysis, as cDNAs with STPB produced proteins with an M of the larger species, while those without STPB had an M similar to the smaller protein species . Taken together, these data establish that a cell's MCP phenotype depends on the content o£ the STP area of the predominant mRNA isoforms.
A role for STP-rich regions (and therefore O-glycosylation) in defining the two major forms of MCP was in part anticipated, since the larger species possesses more sialic acid than the smaller one (19) . Although STPB is only 15 amino acids long, 11 residues are S, T, or P. Thus, the attachment of 0-linked sugars could account for the molecular weight difference between the protein species. Further, the broadness of the forms of MCP is largely accounted for by post-translational modifications, at least in part due to the addition of carbohydrate (19) . It is likely that variability in the number of O-linked sugars attached to the STP-rich areas explains this heterogeneity. That MCP transfected into CHO cells produced mature proteins exhibiting broad bands on gels supports this suggestion . The seven amino acid difference between the two tails may also account for some of the variability in size, although transfectants identical except for their cytoplasmic tails were not separable on SDS-PAGE.
The transfectants bearing the different forms ofMCP will be useful in future studies. For example, up to four forms of MCP are expressed on a single cell. The biologic significance of such diversity for a regulatory membrane protein is unknown and would be interesting to examine. Also, the role of STRrich domains adjacent to a transmembrane domain is not well understood . Several receptor and membrane-bound glycoproteins, such as the low density lipoprotein receptor (38) , the IL-2 receptor (39-41), and another RCA protein, DAF (42, 43) , have STP-rich areas immediately adjacent to their transmembrane domains . While the function of the STP domain is unknown, some evidence suggests that O-glycosylation may protect the protein from proteolysis (44, 45) . Alternative splicing of the STP-rich exons in these genes has not been described,,and MCP is unique in this regard . Interestingly, the leukocyte common antigen family, whose structural gene is also located at 1832 (46) , resembles MCP in that variable splicing among STP-rich exons is used to produce multiple cDNA species . In this gene, though, alternative splicing may be cell specific, and this region, located at the NH2 terminus of the protein, is postulated to be a lectin binding domain. The variation in the STP region of MCP isoforms is a model system to analyze the function of such domains in mammalian proteins.
Finally, the biologic significance of the two cytoplasmic tails will be ofinterest to evaluate. Approximately equal quantities ofMCP forms bearing each tail are expressed on human cells. Previous studies demonstrated that the processing of two precursor forms of MCP varied fourfold (19) . Preliminary studies indicate that the cytoplasmic tail determines this difference, and further analysis ofthis observation should provide insights into the signals required for the processing and compartmentalization of mammalian precursor proteins.
